Exchange: NASDAQ Sector: Healthcare Industry: Medical Distribution
Current Signal: BUY (auto-tracking)
1.00% $72.76
America/New_York / 23 apr 2024 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 9 350.10 mill |
EPS: | 3.16 |
P/E: | 23.03 |
Earnings Date: | May 07, 2024 |
SharesOutstanding: | 128.51 mill |
Avg Daily Volume: | 1.122 mill |
RATING 2024-04-23 |
---|
A+ |
Strong Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Buy | |
Return On Equity: | Neutral | |
Return On Asset: | Buy | |
DE: | Strong Buy | |
P/E: | Strong Buy | |
Price To Book: | Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 2/23 | 3/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE 23.03 | sector: PE -3.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
1.18x |
Company: PE 23.03 | industry: PE 19.46 |
DISCOUNTED CASH FLOW VALUE |
---|
$73.10 (0.47%) $0.339 |
Date: 2024-04-23 |
Expected Trading Range (DAY) |
---|
$ 71.26 - 74.26 ( +/- 2.06%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-20 | Connett Bradford C | Sell | 6 430 | Common Stock, par value $0.01 per share |
2024-03-20 | Bergman Stanley M | Sell | 475 | Common Stock, par value $0.01 per share |
2024-03-18 | Breslawski James P | Sell | 2 907 | Common Stock, par value $0.01 per share |
2024-03-09 | South Ronald N. | Buy | 20 064 | Common Stock, par value $0.01 per share |
2024-03-09 | Mlotek Mark E | Buy | 26 752 | Common Stock, par value $0.01 per share |
INSIDER POWER |
---|
15.79 |
Last 100 transactions |
Buy: 296 615 | Sell: 298 851 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $72.76 (1.00% ) |
Volume | 0.596 mill |
Avg. Vol. | 1.122 mill |
% of Avg. Vol | 53.11 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % | Feb 8 - 15:35 | buy | $74.70 | N/A | Active |
---|
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.